From the King Kong of weight-loss jabs to the Godzilla of the category, the GLP-1 industry is undergoing big changes ...

Up until recently, all three GLP-1 drugs for weight loss were only available in injectable form. However, the FDA approved ...

The obesity treatment market has become more competitive and is rapidly shifting from being centered on pharmaceutical ...

Weight loss jabs such as Wegovy and Mounjaro are being used by an estimated 1.6 million adults in Great Britain per year, ...

Chances are you've heard that the GLP-1s called semaglutide (Ozempic and Wegovy) and liraglutide (Victoza and Saxenda), used for weight management and/or control of Type 2 diabetes, are also good for ...

If your iPhone finally updated to the newest iOS and you aren't really loving it, you're not alone. Since September, iPhone users have had the chance to update their phones to iOS 26, Apple's software ...

Today, Microsoft announced the general availability of Windows 11 25H2, also known as Windows 11 2025 Update. Windows 11 25H2 is a minor update, and it shares the same platform release as Windows 11 ...

Generic Saxenda ® is the first-ever generic GLP-1 indicated for weight loss, addressing increased demand for this category of therapies in the U.S. market. This approval and launch add to Teva’s ...

(RTTNews) - Teva Pharmaceuticals, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (TEVA), Thursday said that the U.S. Food and Drug Administration (FDA) has approved a generic version of ...

Liraglutide, a generic of Saxenda, is approved to treat adults and adolescents who are obese or overweight. Teva Pharmaceuticals has received FDA approval and has launched a generic version of Saxenda ...

Saxenda (liraglutide) is a GLP-1 agonist injection pen medication used to support long-term weight loss in adults with obesity, adults with overweight and weight-related health issues, and certain ...